Skin Condition Clinical Trials
OHSU Department of Dermatology's Clinical Research Team provides expertise in clinical research. We offer many different clinical trials throughout the year throughout various skin conditions. Most trials have a limited number of spots or time allowed to enroll patients.
Currently Enrolling Trials
Pediatric Dupilumab Study
The purpose of this study is to determine the safety and efficacy of the investigational drug in children from 6 months to 6 years of age who have been diagnosed with atopic dermatitis, also known as eczema.
Open label safety study of crisaborole ointment 2% in children aged 3 months to less than 24 months with mild to moderate atopic dermatitis.
The purpose of this study is to learn more about the safety and effectiveness of crisaborole ointment 2% in children younger than 2 years old who have been diagnosed with atopic dermatitis (eczema).
Effects of Calcipotriene Foam, 0.005%, in Pediatric Subjects (Ages 2 to 11
Years) with Plaque Psoriasis
The purpose of this study is to learn more about psoriasis in children and how a foam treatment acts on the body and scalp.
War on Melanoma: Enlisting a cohort of melanoma survivors and their families
The purpose of this data repository, called the Melanoma Community Registry, is to develop a prospective cohort of melanoma patients, family members and friends (controls). This registry will serve as a data repository for future IRB-approved research and thus will collect, store and share data with melanoma researchers for an indeterminate period of time. In addition, our repository will contain identifying codes/numbers that are links to data/samples in other relevant databases. Additionally, it is intended to deliver a ready-to-act group of volunteers to participate in the War on Melanoma campaign to include such things as attending educational symposiums and using their networks to increase awareness of the issue. There is no existing nationwide registry for melanoma research. As patient-centered research advances, a resource like this is needed and can serve as a model.
Our clinical trials in the press
Targeted drug tames atopic eczema in Phase III trials
Eczema - Dupilumab - Dr. Eric Simpson
New Drug for Severe Eczema Is Successful in 2 New Trials
Eczema - Dupilumab - Dr. Jon Hanifin
Are You Bathing Your Baby Too Much?
Pediatric Eczema - Dr. Eric Simpson